Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd | Sector: Pharmaceuticals | ISIN: INE942C01029

Trade

Corporate Actions

27 Jan , 2023

12:00 AM

Results

View Details

27 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

21 Nov , 2022

12:00 AM

Dividend

Dividend amount: 4.4
Announcement date: 21 Nov , 2022

View Details

16 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Oct , 2022

12:00 AM

Results

View Details

22 Jul , 2022

12:00 AM

AGM

Announcement date: 22 Jul , 2022

View Details

20 May , 2022

12:00 AM

Dividend

Dividend amount: 4
Announcement date: 20 May , 2022

View Details

19 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 Jul , 2022

12:00 AM

Results

View Details

12 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

27 Jul , 2022

12:00 AM

BookCloser

View Details

Gujarat Themis Biosyn Ltd News and Update

Adani Power sells Support Properties Private Ltd to AdaniConnex

13 hours ago |
4:03 PM

According to a BSE filing, the parties to the proposed transaction, for which a legally binding memorandum of understanding had previously been signed, had "executed a Share Purchase Agreement and finalized the transaction."

Power Grid Corporation acquires Khavda II-C Transmission Ltd

1 day ago |
4:02 PM

HPCL to build third LPG underground storage facility, in Gujarat

1 day ago |
4:02 PM

Hindustan Zinc's dividend payments may ease Vedanta's debt repayment challe...

IIFL News Service |
1 day ago |
4:02 PM

FINANCIALS

No Data Available To Display Chart

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	972.80	89.99	2,33,407.31	486.73	1.03	4,549.90	108.48
Divis Laboratories Ltd	2,809.00	31.40	74,497.12	310.90	1.07	1,689.83	454.85
Dr Reddys Laboratories Ltd	4,462.75	31.49	74,309.82	324.60	0.67	3,879.60	1,156.21
Cipla Ltd	877.00	25.58	70,787.11	678.52	0.57	3,541.16	291.76
Torrent Pharmaceuticals Ltd	1,517.75	48.99	51,379.40	229.00	1.58	1,826.00	191.38

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Gujarat Themis Biosyn Ltd

Dinesh S Patel
Chairman (Non-Executive)

Sachin D Patel
Director

Vijay Agarwal.
Independent Director

Vikram D Sanghvi
Independent Director

Siddharth Y Kusumgar
Independent Director

Kirandeep Madan
Additional Director

RAHUL DWARAKA SONI
Company Secretary

Summary

Summary Info Not Found

Reports by Gujarat Themis Biosyn Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Gujarat Themis Biosyn Ltd
Investor PresentationConference Call TranscriptConference Call Audio

CALLS						PUTS
Total OI	Chg in Ol	Chg % Ol	LTP	Chg %	Strike Price	Chg %	LTP	Chg % OI	Chg in Ol	Total OI

Gujarat Themis Biosyn Ltd

Expiry Date:

GUJTHEMIS - 29-03-2023

KEY RATIOS

Corporate Actions

SHAREHOLDING SNAPSHOT 24 March , 2023 | 08:26 PM

Knowledge Center

Gujarat Themis Biosyn Ltd News and Update

FINANCIALS

Select Period:

QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

PEER COMPARISON

MORE ABOUT Gujarat Themis Biosyn Ltd

Dinesh S Patel

Sachin D Patel

Vijay Agarwal.

Vikram D Sanghvi

Siddharth Y Kusumgar

Kirandeep Madan

RAHUL DWARAKA SONI

Summary

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

SHAREHOLDING SNAPSHOT
24 March , 2023 | 08:26 PM